Anti-Vav proteins (phospho Y174) antibody
4
(3 리뷰들)
|
(14 제품이 사용된 논문 )
- WB
Unknown
Western blot - Anti-Vav proteins (phospho Y174) antibody (AB47282)
All lanes:
Western blot - Anti-Vav proteins (phospho Y174) antibody (ab47282) at 1/500 dilution
Lane 1:
Extrats from Jurkat cells treated with UV at 30 µg
Lane 2:
Extrats from Jurkat cells untreated at 30 µg
Predicted band size: 78 kDa
false
- WB
CiteAb
Western blot - Anti-Vav proteins (phospho Y174) antibody (AB47282)
Western Blotting using Anti-Vav proteins (phospho Y174) antibody, ab47282. Publication image from Booth, C. et al., 2016, Nat Commun, 27221592. Legend direct from paper.
Synergistic activation of NF-κB is Vav1-dependent.(a) Rested NKL cells were stimulated with NKG2D and/or 2B4 in combination with or without CD94 engagement by receptor crosslinking. Lysates were immunoblotted for pS536-p65, pS276-p65, p65, p-Akt, p-Erk1/2, pY174-Vav1 or actin. The normalized intensities of the phosphorylated p65 relative to p65 are presented. (b) Rested NKL-κB-GFP cells were stimulated with plate-immobilized NKG2D and 2B4 in combination with or without CD94 for 6 h. GFP expression in the reporter NKL cells was analysed by flow cytometry, and representative result (left) and statistical bar charts (right) are shown. Values represent mean±s.d. (c) Rested NKL cells transfected with control siRNA or Vav1-specific siRNA were stimulated with NKG2D and/or 2B4 by receptor crosslinking. Lysates were immunoblotted for pS536-p65, pS276-p65, p65, p-Akt, p-Erk1/2, Vav1 or actin. The normalized intensities of the phosphorylated p65 relative to p65 are presented. (d) Rested NKL-κB-GFP cells transfected with control siRNA or Vav1-specific siRNA were stimulated with plate-immobilized NKG2D and 2B4 for 6 h. GFP expression in the reporter NKL cells was analysed by flow cytometry, and representative result (left) and statistical bar charts (right) are shown. Values represent mean±s.d. **P<0.01; ***P<0.001 (two-sided Student's t-test). Data are representative of at least three independent experiments.
false
- WB
CiteAb
Western blot - Anti-Vav proteins (phospho Y174) antibody (AB47282)
Western Blotting using Anti-Vav proteins (phospho Y174) antibody, ab47282. Publication image from Booth, C. et al., 2016, Nat Commun, 27221592. Legend direct from paper.
Defective cytotoxic degranulation and Vav1 activation in XLP1 NK cells following coactivation.(a,b) Primary rested NK cells after expansion from normal or XLP1 donors were mixed with P815 target cells as indicated in the presence of fluorochrome-conjugated anti-CD107a mAb. After incubation for 2 h, cells were analysed using flow cytometry as described in Fig. 5b. (a) Representative result is shown. (b) Percent increase of CD107a+ NK cells obtained from individual normal or XLP1 donors after stimulation with the indicated receptors relative to CD107a+ NK cells without stimulation (δCD107a+ cells). Values represent mean±s.d. (c) Representative FACS profiles showing the expression levels of the NKp30, NKp44, NKp46, NKG2D, NKG2C, DNAM-1, 2B4 and CD16 receptors (shaded histogram) on primary expanded NK cells obtained from normal or XLP1 donors. Isotype control staining is shown as the solid lines. (d) Primary rested NK cells after expansion from normal or XLP1 patient donors were treated as in Fig. 5d to stimulate NKG2D and/or 2B4 for 2 min. Lysates were immunoblotted with anti-pY174-Vav1 Ab and reprobed for Vav1. The normalized intensities of the phosphorylated Vav1 relative to total Vav1 are presented. Representative result (left) and statistical bar charts for pooled data from three different donors (right) are shown. Values represent mean±s.e.m. *P<0.05 (two-sided Student's t-test).
false
- WB
CiteAb
Western blot - Anti-Vav proteins (phospho Y174) antibody (AB47282)
Western Blotting using Anti-Vav proteins (phospho Y174) antibody, ab47282. Publication image from Booth, C. et al., 2016, Nat Commun, 27221592. Legend direct from paper.
Synergistic activation of NF-κB is Vav1-dependent.(a) Rested NKL cells were stimulated with NKG2D and/or 2B4 in combination with or without CD94 engagement by receptor crosslinking. Lysates were immunoblotted for pS536-p65, pS276-p65, p65, p-Akt, p-Erk1/2, pY174-Vav1 or actin. The normalized intensities of the phosphorylated p65 relative to p65 are presented. (b) Rested NKL-κB-GFP cells were stimulated with plate-immobilized NKG2D and 2B4 in combination with or without CD94 for 6 h. GFP expression in the reporter NKL cells was analysed by flow cytometry, and representative result (left) and statistical bar charts (right) are shown. Values represent mean±s.d. (c) Rested NKL cells transfected with control siRNA or Vav1-specific siRNA were stimulated with NKG2D and/or 2B4 by receptor crosslinking. Lysates were immunoblotted for pS536-p65, pS276-p65, p65, p-Akt, p-Erk1/2, Vav1 or actin. The normalized intensities of the phosphorylated p65 relative to p65 are presented. (d) Rested NKL-κB-GFP cells transfected with control siRNA or Vav1-specific siRNA were stimulated with plate-immobilized NKG2D and 2B4 for 6 h. GFP expression in the reporter NKL cells was analysed by flow cytometry, and representative result (left) and statistical bar charts (right) are shown. Values represent mean±s.d. **P<0.01; ***P<0.001 (two-sided Student's t-test). Data are representative of at least three independent experiments.
false
Reactivity 정보
특성 및 보관 정보
제형
Purification 테크닉
Purification 관련 사항
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
대체 명칭 보기
제품이 사용된 논문 (14)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2400920 PubMed38828677
2024
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 120:e2300987120 PubMed37307442
2023
Applications
Unspecified application
Species
Unspecified reactive species
BMC biology 20:189 PubMed36002835
2022
Applications
Unspecified application
Species
Unspecified reactive species
Biochemical and biophysical research communication 516:914-920 PubMed31272717
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular biology of the cell 28:3397-3414 PubMed28855374
2017
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 7:1885 PubMed28507287
2017
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 7:11686 PubMed27221592
2016
Applications
Unspecified application
Species
Unspecified reactive species
Molecular biology of the cell 26:3215-28 PubMed26202465
2015
Applications
Unspecified application
Species
Unspecified reactive species
Journal of ovarian research 7:32 PubMed24628852
2014
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federa 26:2049-59 PubMed22278940
2012
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com